ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 16 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $46,000 | +4.5% | 55,000 | 0.0% | 0.00% | – |
| Q1 2016 | $44,000 | -12.0% | 55,000 | 0.0% | 0.00% | – |
| Q4 2015 | $50,000 | -7.4% | 55,000 | 0.0% | 0.00% | – |
| Q3 2015 | $54,000 | -32.5% | 55,000 | -14.1% | 0.00% | – |
| Q2 2015 | $80,000 | -66.4% | 64,000 | -72.2% | 0.00% | – |
| Q4 2013 | $238,000 | +6.7% | 230,000 | +17.9% | 0.00% | – |
| Q3 2013 | $223,000 | – | 195,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,000,000 | $53,278,000 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $6,018,000 | 0.85% |
| CSS LLC/IL | 10,546,000 | $12,816,000 | 0.62% |
| Verition Fund Management LLC | 3,400,000 | $4,025,000 | 0.43% |
| Redmile Group, LLC | 4,000,000 | $4,761,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,600,000 | $23,231,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,139,000 | $13,378,000 | 0.20% |
| LINDEN ADVISORS LP | 2,000,000 | $2,374,000 | 0.11% |
| Fernwood Investment Management, LLC | 90,000 | $106,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,909,000,000 | 0.09% |